Lassa virus glycoprotein complex (GPC) | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19,763 results for “Lassa virus glycoprotein complex (GPC)”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Prevalence and Incidence of Lassa Virus Infection in Southern Mali

8,524 participants · First posted Dec 20, 2018

PACTR202108781239363

A study to assess a new Lassa Virus Vaccine in healthy volunteers

108 participants

Active, not recruiting

A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath

114 participants · First posted Mar 11, 2021

A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)

60 participants · First posted Aug 13, 2019

Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, Mali

601 participants · First posted Dec 8, 2014

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

27 participants · First posted Feb 7, 2025

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

15 participants · First posted Mar 12, 2018

Cardiovascular Function and Ribavirin PK/PD in Lassa Fever in Lassa Fever

158 participants · First posted Feb 26, 2020

LAssa Fever Adjunct Treatment With DEXamethasone

42 participants · First posted Jan 25, 2024

ISTH/ANRS 0409s INTEGRATE Lassa Fever Study

1,755 participants · First posted Jan 18, 2024

Page 1 of 1059